Osteogenesis Imperfecta - 26 Studies Found
Completed |
: Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2011-08-04 : Drug: BPS804 |
Completed |
: Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab : Osteogenesis Imperfecta : 2013-02-14 : Drug: Denosumab Denosumab will be given subcutaneously in a dosage of 1mg/kg body weight every 12 weeks. |
Completed |
: Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study : Osteogenesis Imperfecta : 2005-09-12 : Biological: Bone marrow transplant |
Active, not recruiting |
: Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2014-06-12 : Biological: Mesenchymal Stem Cells Mesenchymal Stem Cell Infusions |
Not yet recruiting |
: Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2016-10-13 : Drug: Fresolimumab The purpose of this study is to determine if fresolimumab is safe as a treatment for |
Recruiting |
: The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2012-08-16 :
|
Completed |
: Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2014-11-19 : Drug: Alendronate Alendronate was administrated as 70 mg/week orally (Fosamax, Merck Sharp & Dohme |
Completed |
: Whole Body Vibration Training in Children With Osteogenesis Imperfecta and Limited Mobility : Osteogenesis Imperfecta : 2017-01-19 : Device: Galileo M Motorized board producing side-to-side alternating vertical sinusoidal (rotational) vi |
Recruiting |
: BBD Longitudinal Study of Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2015-04-29 |
Completed |
: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta :
|